Animas Vibe Plus CGMS
The FDA has approved the Animas Vibe insulin pump and continuous glucose monitoring (CGM) system for management of patients with diabetes who require insulin. The integrated system, which features Dexcom G4 Platinum sensing technology, allows patients to view glucose data and administer insulin from the pump. The latest glucose readings appear on the pump screen along with a view of glucose highs, lows and rates of change over time. These data complement fingerstick testing results and can be used to guide or adjust immediate and long-term insulin delivery. Additional features include: Dexcom CGM sensor technology that is approved for up to seven days of continuous wear and waterproof up to 12 feet for 24 hours. The Dexcom G4 Platinum transmitter is water-resistant for up to 8 feet for 24 hours, and features customizable alarms that signal high and low glucose levels, a high-contrast color screen with color-coded graphs and arrows to indicate direction and rate of glucose change.